Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for “Ending the Epidemic”

Don C.Des Jarlais, Kamyar Arasteh, Courtney McKnight, Jonathan Feelemyer, Holly Hagan, Hannah L.F. Cooper, Aimee N.C. Campbell, Susan Tross, David C. Perlman

Research output: Contribution to journalArticlepeer-review


New York City has experienced the largest HIV epidemic among persons who use psychoactive drugs. We examined progress in placing HIV seropositive persons who inject drugs (PWID) and HIV seropositive non-injecting drug users (NIDU) onto antiretroviral treatment (ART) in New York City over the last 15 years. We recruited 3511 PWID and 3543 NIDU from persons voluntarily entering drug detoxification and methadone maintenance treatment programs in New York City from 2001 to 2014. HIV prevalence declined significantly among both PWID and NIDU. The percentage who reported receiving ART increased significantly, from approximately 50 % (2001–2005) to approximately 75 % (2012–2014). There were no racial/ethnic disparities in the percentages of HIV seropositive persons who were on ART. Continued improvement in ART uptake and TasP and maintenance of other prevention and care services should lead to an “End of the AIDS Epidemic” for persons who use heroin and cocaine in New York City.

Original languageEnglish (US)
Pages (from-to)353-362
Number of pages10
JournalAIDS and Behavior
Issue number2
StatePublished - Feb 1 2016


  • Antiretroviral therapy
  • HIV
  • Non-injection drug users
  • Persons who inject drugs
  • Treatment as prevention

ASJC Scopus subject areas

  • Social Psychology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for “Ending the Epidemic”'. Together they form a unique fingerprint.

Cite this